RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MARTINELLI G
Collezione AOU San Luigi di Orbassano

Items : 24

Droplet Digital PCR for BCR-ABL1 Monitoring in Diagnostic Routine: Ready to Start? in Cancers / Cancers (Basel). 2021 Oct 30;13(21):5470. doi: 10.3390/cancers13215470.

2021
AOU San Luigi di Orbassano

Bochicchio MT; Petiti J; Berchialla P; Izzo B; Giugliano E; Ottaviani E; Errichiello S; Rege-Cambrin G; Venturi C; Luciano L; Daraio F; Calistri D; Rosti G; Saglio G; Martinelli G; Pane F; Cilloni D; Gottardi EM; Fava C;

Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study. in Intensive care medicine / Intensive Care Med. 2021 Apr;47(4):444-454. doi: 10.1007/s00134-021-06373-7. Epub 2021 Mar 20.

2021
AOU San Luigi di Orbassano
ASL Cuneo 1
ASL Città di Torino
ASL Cuneo 2

Ingallina G; Burkert J; Infante MN; Covella M; Giostra F; Grignaschi A; Boccatonda A; Salinaro F; Zattera C; Secco G; McDermott C; Miralles-Aguiar F; Perani C; Vetrugno L; Cristoni L; Boero E; Martinelli G; Ferre R; Navalesi P; Fraga DN; Stefanone V; Corradi F; Nazerian P; Villén T; Deol PS; Agricola E; Lamorte A; Nogué-Bou R; Lanotte A; et alii...

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. in Blood / Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969.

2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Cavo M; Baccarani M; Rosti G; Tenti E; Laginestra MA; Pileri SA; Percesepe A; Mignone F; Vigneri P; Saglio G; Pane F; Errichiello S; Serra A; Stella S; Calistri E; Annunziata M; Bocchia M; Musolino C; Attolico I; Coluzzi S; Capodanno I; Girasoli M; Sancetta R; Salvucci M; Binotto G; Abruzzese E; D'Adda M; di Bona E; di Raimondo F; et alii...

Myelodysplastic syndromes with hypocellular marrow: Clinical characteristics and evaluation of outcome in HemaSphere

2018
ASL Biella
ASL Città di Torino
ASL Asti
ASL Torino 4
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Alessandria
ASL Novara

Santini V; Gioia D; Masiera E; Poloni A; Ferrero D; Fragasso A; Finelli C; Salvi F; Gaidano G; Oliva EN; Catarini M; Cametti G; Bonferroni M; Danise P; Tassara R; Allione B; Cilloni D; Castelli A; Centurioni R; Ciravegna G; Visani G; Musto P; Balleari E; Biale L; Capelli D; Frairia C; Galimberti S; Giaccone L; Macchi S; et alii...

Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia. in Haematologica / Haematologica. 2017 Sep;102(9):1530-1536. doi: 10.3324/haematol.2017.169532. Epub 2017 Jun 1.

2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Gugliotta G; Castagnetti F; Breccia M; Albano F; Iurlo A; Intermesoli T; Abruzzese E; Levato L; D'Adda M; Pregno P; Cavazzini F; Stagno F; Martino B; La Barba G; Sorà F; Tiribelli M; Bigazzi C; Binotto G; Bonifacio M; Caracciolo C; Soverini S; Foà R; Cavo M; Martinelli G; Pane F; Saglio G; Baccarani M; Rosti G;

5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia. in Journal of hematology & oncology / J Hematol Oncol. 2017 Jan 18;10(1):18. doi: 10.1186/s13045-016-0382-y.

2017
AOU San Luigi di Orbassano

Marconi C; Canobbio I; Bozzi V; Pippucci T; Simonetti G; Melazzini F; Angori S; Martinelli G; Saglio G; Torti M; Pastan I; Seri M; Pecci A;

The automated molecular technique “ultra” allows a sensitive and accurate BCR-ABL1 quantification in patients affected by chronic myeloid leukemia in Haematologica

2017
AOU San Luigi di Orbassano

Guerrini F; Izzo B; Gottardi E; Bochicchio MT; Morganti R; Grassi S; Barate C; Erricchiello S; Pedri R; Metelli MR; Lorenzatti R; Di Vita A; Domenichini C; Saglio G; Pane F; Petrini M; Martinelli G; Galimberti S;

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients. in Haematologica / Haematologica. 2016 Oct;101(10):1200-1207. doi: 10.3324/haematol.2016.144949. Epub 2016 Jul 28.

2016
AOU San Luigi di Orbassano

Castagnetti F; Breccia M; Gugliotta G; Martino B; D'Adda M; Stagno F; Carella AM; Avanzini P; Tiribelli M; Trabacchi E; Visani G; Gobbi M; Salvucci M; Levato L; Binotto G; Capalbo SF; Bochicchio MT; Soverini S; Cavo M; Martinelli G; Alimena G; Pane F; Saglio G; Rosti G; Baccarani M;

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia. in American journal of hematology / Am J Hematol. 2016 Jun;91(6):617-22. doi: 10.1002/ajh.24362. Epub 2016 Apr 24.

2016
AOU San Luigi di Orbassano
AOU Novara

Pane F; Martinelli G; Alimena G; Cavo M; Soverini S; Venturi C; Levato L; Musolino C; Pia Falcone A; Lunghi M; Tiribelli M; Cavazzini F; Bocchia M; D'Adda M; Luciano L; Stagno F; Albano F; Martino B; Abruzzese E; Rege-Cambrin G; Usala E; Carella AM; Gozzini A; Breccia M; Castagnetti F; Gugliotta G; Saglio G; Rosti G; Baccarani M; et alii...

In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants. in BMC cancer / BMC Cancer. 2016 Aug 2;16:572. doi: 10.1186/s12885-016-2635-0.

2016
AOU San Luigi di Orbassano

Soverini S; De Benedittis C; Castagnetti F; Gugliotta G; Mancini M; Bavaro L; Machova Polakova K; Linhartova J; Iurlo A; Russo D; Pane F; Saglio G; Rosti G; Cavo M; Baccarani M; Martinelli G;

Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia. in Haematologica / Haematologica. 2015 Sep;100(9):1146-50. doi: 10.3324/haematol.2015.129221. Epub 2015 Jun 25.

2015
AOU San Luigi di Orbassano

Gugliotta G; Castagnetti F; Breccia M; Levato L; D'Adda M; Stagno F; Tiribelli M; Salvucci M; Fava C; Martino B; Cedrone M; Bocchia M; Trabacchi E; Cavazzini F; Usala E; Russo Rossi A; Bochicchio MT; Soverini S; Alimena G; Cavo M; Pane F; Martinelli G; Saglio G; Baccarani M; Rosti G;

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib. in Leukemia / Leukemia. 2015 Sep;29(9):1823-31. doi: 10.1038/leu.2015.152. Epub 2015 Jun 19.

2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Castagnetti F; Gugliotta G; Breccia M; Stagno F; Iurlo A; Albano F; Abruzzese E; Martino B; Levato L; Intermesoli T; Pregno P; Rossi G; Gherlinzoni F; Leoni P; Cavazzini F; Venturi C; Soverini S; Testoni N; Alimena G; Cavo M; Martinelli G; Pane F; Saglio G; Rosti G; Baccarani M;

Differences among young adults, adults and elderly chronic myeloid leukemia patients. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jan;26(1):185-192. doi: 10.1093/annonc/mdu490. Epub 2014 Oct 30.

2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Castagnetti F; Gugliotta G; Baccarani M; Breccia M; Specchia G; Levato L; Abruzzese E; Rossi G; Iurlo A; Martino B; Pregno P; Stagno F; Cuneo A; Bonifacio M; Gobbi M; Russo D; Gozzini A; Tiribelli M; de Vivo A; Alimena G; Cavo M; Martinelli G; Pane F; Saglio G; Rosti G;

Long-term outcome of alternating nilotinib 400 mg twice daily and imatinib 400 mg once daily as first-line treatment of chronic myeloid leukemia: A phase 2 study of the gimema cml working party in Haematologica

2015
AOU San Luigi di Orbassano

Gugliotta G; Castagnetti F; Breccia M; Gozzini A; Stagno F; Rege-Cambrin G; Carella AM; Luciano L; Specchia G; Abruzzese E; Martino B; Usala E; Rossi G; Bocchia M; Cavazzini F; Tiribelli M; Venturi C; Soverini S; Alimena G; Cavo M; Pane F; Martinelli G; Saglio G; Rosti G; Baccarani M;

Cytogenetic response, molecular response and outcome of elderly PH+ CML patients with stable complete cytogenetic response after 4-years of intermittent treatment with imatinib (interim) in Haematologica

2013
AOU San Luigi di Orbassano

Russo D; Malagola M; Martinelli G; Skert C; Soverini S; Iacobucci I; De Vivo A; Testoni N; Castagnetti F; Gugliotta G; Turri D; Bergamaschi M; Pregno P; Pungolino E; Stagno F; Breccia M; Martino B; Intermesoli T; Fava C; Abruzzese E; Tiribelli M; Bigazzi C; Cesana BM; Rosti G; Baccarani M;

High eutos score is predictive for adverse outcome in early chronic phase CML patients treated with nilotinib-based regimens in Haematologica

2012
AOU San Luigi di Orbassano

Castagnetti F; Gugliotta G; Palandri F; Breccia M; Levato L; Stagno F; Rege Cambrin G; Luciano L; Specchia G; Abruzzese E; Gozzini A; Martino B; Capucci A; Intermesoli T; Tiribelli M; Cedrone M; Cavazzini F; Soverini S; Testoni N; Saglio G; Martinelli G; Pane F; Alimena G; Rosti G; Baccarani M;

Frontline nilotinib 400 mg bid in early chronic phase chronic myeloid leukemia: Stable results beyond 4 years-the gimema CML WP trial CML0307 in Haematologica

2012
AOU San Luigi di Orbassano

Gugliotta G; Castagnetti F; Breccia M; Levato L; Capucci A; Tiribelli M; Zaccaria A; Bocchia M; Cuneo A; Stagno F; Specchia G; Musso M; Martino B; Cedrone M; Intermesoli T; Palandri F; Soverini S; Baldazzi C; Durante S; Testoni N; Alimena G; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G;

Chronic eosinophilic leukaemia (CEL) with FIP1L1-PDGFRalpha rearrangement (F/P): The response to imatinib (IM) is durable. a report of 33 patients with a follow -up of 30 to 92 months in Blood

2009
AOU San Luigi di Orbassano

Rondoni M; Ottaviani E; Cilloni D; Paolo Piccaluga P; Paolini S; Iacobucci I; Soverini S; Merante S; Messa F; Buccisano F; Tiribelli M; Pane F; Saglio G; Lauria F; Baccarani M; Martinelli G;

The long-term durability of molecular responses in patients with FIP1L1-PDGFRA chronic heosinophilic leukemia treated with imatinib: The italian hes0203 experience after a 4-year follow-up in Haematologica

2009
AOU San Luigi di Orbassano

Rondoni M; Cilloni D; Paolini S; Ottaviani E; Messa F; Piccaluga PP; Merante S; Buccisano F; Titibelli M; Vigna E; Spadea A; Messa E; Pane F; Saglio G; Lauria F; Baccarani M; Martinelli G;

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: A phase 2 trial of the GIMEMA CML Working Party in Blood

2009
AOU San Luigi di Orbassano

Castagnetti F; Palandri F; Amabile M; Testoni N; Luatti S; Soverini S; Iacobucci I; Breccia M; Cambrin GR; Stagno F; Specchia G; Galieni P; Iuliano F; Pane F; Saglio G; Alimena G; Martinelli G; Baccarani M; Rosti G;

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy. in Haematologica / Haematologica. 2008 Jun;93(6):921-4. doi: 10.3324/haematol.12165. Epub 2008 Apr 28.

2008
AOU San Luigi di Orbassano

Cilloni D; Messa F; Arruga F; Defilippi I; Gottardi E; Fava M; Carturan S; Catalano R; Bracco E; Messa E; Nicoli P; Diverio D; Sanz MA; Martinelli G; Lo-Coco F; Saglio G;

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR?- positive hypereosinophilic syndrome. Results of a multicenter prospective study in Haematologica

2007
AOU San Luigi di Orbassano

Baccarani M; Cilloni D; Rondoni M; Ottaviani E; Messa F; Merante S; Tiribelli M; Buccisano F; Testoni N; Gottardi E; De Vivo A; Giugliano E; Iacobucci I; Paolini S; Soverini S; Rosti G; Rancati F; Astolfi C; Pane F; Saglio G; Martinelli G;

Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow in Blood

2003
AOU San Luigi di Orbassano

Gorin NC; Labopin M; Rocha V; Arcese W; Beksac M; Gluckman E; Ringden O; Ruutu T; Reiffers J; Bandini G; Falda M; Zikos P; Willemze R; Frassoni F; Abecasis M; Abráhamová J; Afanassiev BV; Aglietta M; Alabdulaaly A; Aleinikova O; Paolo Alessandrino E; Al Shemmari SH; Amadori D; Amadori S; Amos T; Andolina M; Andreesen R; Angelucci E; Anhuf J; et alii...

BCR/ABL transcripts and leukemia phenotype: an unsolved puzzle. in Leukemia & lymphoma / Leuk Lymphoma. 1997 Jul;26(3-4):281-6. doi: 10.3109/10428199709051777.

1997
AOU San Luigi di Orbassano

Saglio G; Pane F; Martinelli G; Guerrasio A;